A pan-cancer study revealed the mutual exclusivity of TP53 mutations with certain driver mutations (such as VHL mutations in renal clear cell carcinoma), but not with APC mutations in colorectal cancer [81] (see Figure 2B for examples). The gene discussed is TP53; the disease is cancer.